Poly Medicure Ltd

Poly Medicure Ltd, a small-cap player in the healthcare services sector, has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Sell, underscores a complex valuation landscape that investors must carefully navigate amid broader market and sector trends.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 June 2026, providing investors with an up-to-date view of the company's performance and outlook.

Poly Medicure Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a bearish trend. The stock’s price has declined sharply, reflecting a deteriorating outlook amid mixed technical signals and a downgrade in its Mojo Grade to Sell from Strong Sell as of 11 Feb 2026.

Poly Medicure Ltd experienced a significant intraday decline on 27 May 2026, touching a low of Rs 1,339, down 7.0% from its previous close. The stock underperformed its sector and broader market indices, reflecting persistent downward pressure amid heightened volatility and a cautious market environment.

Poly Medicure Ltd, a notable player in the Healthcare Services sector, has experienced a marked shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, coupled with a recent downgrade in its Mojo Grade to Sell, highlights growing concerns over the stock’s price attractiveness amid broader market pressures and sector dynamics.

Poly Medicure Ltd., India's second-largest healthcare services company by market capitalisation, reported a concerning fourth quarter for FY26, with consolidated net profit plummeting 27.81% year-on-year to ₹66.29 crores despite revenue hitting a record high. The medical devices manufacturer, with a market capitalisation of ₹16,238 crores, saw its shares decline 3.78% to ₹1,538.35 following the results, as investors grappled with sharply compressed margins and deteriorating profitability metrics that overshadowed the company's top-line expansion.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Poly Medicure Ltd, a small-cap player in the Healthcare Services sector, has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive one. This change, coupled with its recent market performance and peer comparisons, raises important questions about the stock’s price attractiveness for investors amid evolving market dynamics.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd, a small-cap player in the Healthcare Services sector, has exhibited a notable shift in its technical parameters, moving from a bearish to a mildly bearish trend. Despite a recent day gain of 1.90%, the stock’s technical indicators present a complex picture, with some suggesting cautious optimism while others maintain a bearish outlook. This article analyses the latest momentum, technical signals, and comparative performance to provide a comprehensive view for investors.

The Sensex declined by 1.92% on 1 Apr 2026, while Poly Medicure Ltd surged 7.38%, outperforming its Healthcare Services sector by 0.44 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.